Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,562 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lung cancer screening.
Adams SJ, Stone E, Baldwin DR, Vliegenthart R, Lee P, Fintelmann FJ. Adams SJ, et al. Among authors: stone e. Lancet. 2023 Feb 4;401(10374):390-408. doi: 10.1016/S0140-6736(22)01694-4. Epub 2022 Dec 20. Lancet. 2023. PMID: 36563698 Review.
USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study.
Tammemägi MC, Ruparel M, Tremblay A, Myers R, Mayo J, Yee J, Atkar-Khattra S, Yuan R, Cressman S, English J, Bedard E, MacEachern P, Burrowes P, Quaife SL, Marshall H, Yang I, Bowman R, Passmore L, McWilliams A, Brims F, Lim KP, Mo L, Melsom S, Saffar B, Teh M, Sheehan R, Kuok Y, Manser R, Irving L, Steinfort D, McCusker M, Pascoe D, Fogarty P, Stone E, Lam DCL, Ng MY, Vardhanabhuti V, Berg CD, Hung RJ, Janes SM, Fong K, Lam S. Tammemägi MC, et al. Among authors: stone e. Lancet Oncol. 2022 Jan;23(1):138-148. doi: 10.1016/S1470-2045(21)00590-8. Epub 2021 Dec 11. Lancet Oncol. 2022. PMID: 34902336 Free PMC article.
Economic impact of using risk models for eligibility selection to the International lung screening Trial.
Cressman S, Weber MF, Ngo PJ, Wade S, Behar Harpaz S, Caruana M, Tremblay A, Manser R, Stone E, Atkar-Khattra S, Karikios D, Ho C, Fernandes A, Yi Weng J, McWilliams A, Myers R, Mayo J, Yee J, Yuan R, Marshall HM, Fong KM, Lam S, Canfell K, Tammemägi MC. Cressman S, et al. Among authors: stone e. Lung Cancer. 2023 Feb;176:38-45. doi: 10.1016/j.lungcan.2022.12.011. Epub 2022 Dec 22. Lung Cancer. 2023. PMID: 36592498 Clinical Trial.
Lung cancer screening: the hidden public health emergency.
Stone E, Dodd RH, Marshall H, Bonevski B, Rankin NM. Stone E, et al. Public Health Res Pract. 2023 Mar 15;33(1):3312302. doi: 10.17061/phrp3312302. Public Health Res Pract. 2023. PMID: 36918390 Free article.
Advances in lung cancer: a ground-breaking decade.
Stone E, Myers R. Stone E, et al. Lancet Respir Med. 2023 May;11(5):407-409. doi: 10.1016/S2213-2600(23)00133-9. Lancet Respir Med. 2023. PMID: 37147028 No abstract available.
Recreational vaping ban in Australia-policy failure or masterstroke?
Stone E, Evison M, van Zyl-Smit RN, Andarini S, Shah S, Vandeleur M. Stone E, et al. Lancet. 2023 Nov 1:S0140-6736(23)02298-5. doi: 10.1016/S0140-6736(23)02298-5. Online ahead of print. Lancet. 2023. PMID: 37924826 No abstract available.
"We need to work towards it, whatever it takes."-participation factors in the acceptability and feasibility of lung cancer screening in Australia: the perspectives of key stakeholders.
Dodd RH, Sharman AR, Yap ML, Stone E, Marshall H, Rhee J, McCullough S, Rankin NM. Dodd RH, et al. Among authors: stone e. Transl Lung Cancer Res. 2024 Feb 29;13(2):240-255. doi: 10.21037/tlcr-23-623. Epub 2024 Feb 21. Transl Lung Cancer Res. 2024. PMID: 38496699 Free PMC article.
1,562 results